This suggests that subtle changes caused by p110α PI3K in the survival and function of T cell subpopulations during adulthood have a profound impact on the development of EAE, confirming the potential therapeutic interest of PI3K isoforms in MS. This evidence concerns the gene PIK3CD and myeloid sarcoma.